OxyPharma (Rabeximod Rights) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

OxyPharma (Rabeximod Rights) General Information

Description

A clinical candidate drug used for the treatment of rheumatoid arthritis. The drug belongs to a new molecular class and has displayed a statistically significant therapeutic effect in a placebo-controlled phase 2-studies in rheumatoid arthritis comprising more than 200 patients.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Box 47041
  • 100 74 Stockholm
  • Sweden
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Cyxone
Corporate Office
  • Box 47041
  • 100 74 Stockholm
  • Sweden

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OxyPharma (Rabeximod Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OxyPharma (Rabeximod Rights)‘s full profile, request access.

Request a free trial

OxyPharma (Rabeximod Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore OxyPharma (Rabeximod Rights)‘s full profile, request access.

Request a free trial

OxyPharma (Rabeximod Rights) FAQs

  • Where is OxyPharma (Rabeximod Rights) headquartered?

    OxyPharma (Rabeximod Rights) is headquartered in Stockholm, Sweden.

  • What industry is OxyPharma (Rabeximod Rights) in?

    OxyPharma (Rabeximod Rights)’s primary industry is Buildings and Property.

  • Is OxyPharma (Rabeximod Rights) a private or public company?

    OxyPharma (Rabeximod Rights) is a Private company.

  • What is OxyPharma (Rabeximod Rights)’s current revenue?

    The current revenue for OxyPharma (Rabeximod Rights) is .

  • Who are OxyPharma (Rabeximod Rights)’s investors?

    OxyPharma has invested in OxyPharma (Rabeximod Rights).

  • When was OxyPharma (Rabeximod Rights) acquired?

    OxyPharma (Rabeximod Rights) was acquired on 14-Jun-2017.

  • Who acquired OxyPharma (Rabeximod Rights)?

    OxyPharma (Rabeximod Rights) was acquired by Cyxone.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »